Omnia Medical

Omnia Medical is a private U.S. medical device company focused on orthopedic and spine implants, with particular emphasis on sacroiliac joint stabilization, spine fusion, vertebral body replacement, and biologic graft products. The company develops physician-oriented surgical solutions intended to improve reproducibility, reduce operative burden, and support better patient outcomes. Its commercial portfolio includes the PsiF family for SI joint procedures, TiBrid and Rotary interbody devices, Boxcar vertebral body replacement, and biologic products such as DBLogix and CeLLogix. In January 2026, Omnia announced the broad commercial launch of its FDA-cleared PsiF DNA sacroiliac joint stabilization system after receiving 510(k) clearance in May 2025. The company is headquartered in Morgantown, West Virginia and operates as an active private medtech business rather than a drug-development biotech company.